The most probable cause of IDO enzyme activation in COVID-19 is the increased level of pro-inflammatory cytokines including IFN-γ, IL-1β and IL-6 [54, 55] and activated oxidative stress pathways [56], which both potently stimulate IDO [26, 57]. Here, IL1B is linked to COVID-19.